Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Tech Transfer Roundup: Inside The Law That Transformed The Research Landscape
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
Japan's BioComo Pursues Novel Ligand Approach To Immuno-Oncology
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Device/Diagnostics Quarterly Deal Statistics, Q3 2015
$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.
Start-Up Quarterly Statistics, Q3 2015
Start-ups raised $2.57 billion in Q3. Biopharma companies penned 23 alliances; 11 acquisitions were signed, none in the diagnostics industry.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Fraunhofer EMFT
- Fraunhofer Research Institution for Microsystems
- Solid State Technologies EMFT
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.